• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Nicox launches Sjögren’s diagnostic test

Article

Sjö is a proprietary laboratory test developed by Immco Diagnostics Inc. which combines traditional markers with three novel, proprietary biomarkers, allowing earlier detection of the disease.

Sophia Antipolis, France-Nicox S.A.recently launched announces that Sjö, an advanced diagnostic panel for the early detection of Sjögren's Syndrome. Nicox also partnered with the Sjögren's Syndrome Foundation to raise awareness among eye care professionals of the disease. Sjögren's Syndrome is estimated to affect about 4 million people in the U.S., with 3 million undiagnosed.

Sjö is a proprietary laboratory test developed by Immco Diagnostics Inc. which combines traditional markers with three novel, proprietary biomarkers, allowing earlier detection of the disease.

Nicox has partnered with the Sjögren's Syndrome Foundation to raise awareness of the prevalence, seriousness, and significance of Sjögren's Syndrome to eyecare professionals. A targeted media campaign over the next few months will aim to educate about the disease and the role they can play in early detection.

Related Videos
Mila Ioussifova, OD, FAAO
Tracy Doll, OD, FAAO
Lisa Hornick, OD, MBA, FAAO
Justin Schweitzer, OD, FAAO, and Selina McGee, OD, FAAO, Dipl ABO, discuss their AAOpt presentation on the intersection of dry eye and glaucoma
© 2023 MJH Life Sciences

All rights reserved.